Prostate-specific Antigen Bounce After Intensity-modulated Radiotherapy for Prostate Cancer

Specific Antigen ◽

Intensity Modulated

Normalization of prostate specific antigen in patients treated with intensity modulated radiotherapy for clinically localized prostate cancer

Radiation Oncology ◽

10.1186/1748-717x-5-80 ◽

2010 ◽

Vol 5 (1) ◽

pp. 80 ◽

Cited By ~ 5

Author(s):

Matthew D Schmitz ◽

Gilbert DA Padula ◽

Patrick Y Chun ◽

Alan T Davis

Keyword(s):

Prostate Cancer ◽

Specific Antigen ◽

Localized Prostate Cancer ◽

Intensity Modulated

Normalization of prostate specific antigen (PSA) in patients treated with intensity modulated radiotherapy (IMRT) for clinically localized prostate cancer

Journal of Clinical Oncology ◽

10.1200/jco.2005.23.16_suppl.4771 ◽

2005 ◽

Vol 23 (16_suppl) ◽

pp. 4771-4771

Author(s):

P. Y. Chun ◽

G. D. A. Padula ◽

M. H. Rahbar ◽

J.-P. He ◽

T. Bichay ◽

...

Keyword(s):

Prostate Cancer ◽

Specific Antigen ◽

Localized Prostate Cancer ◽

Intensity Modulated

High-Dose Salvage Intensity-Modulated Radiotherapy With or Without Androgen Deprivation After Radical Prostatectomy for Rising or Persisting Prostate-Specific Antigen: 5-Year Results

European Urology ◽

10.1016/j.eururo.2011.04.021 ◽

2011 ◽

Vol 60 (4) ◽

pp. 842-849 ◽

Cited By ~ 58

Author(s):

Piet Ost ◽

Nicolaas Lumen ◽

An-Sofie Goessaert ◽

Valérie Fonteyne ◽

Bart De Troyer ◽

...

Keyword(s):

Radical Prostatectomy ◽

Specific Antigen ◽

Androgen Deprivation ◽

High Dose ◽

Intensity Modulated ◽

Antigen 5

197: Prostate Cancer Screening Strategies with Rescreening Interval Determined by Individual Baseline Prostate-Specific Antigen Values are Cost-Effective

10.1016/s0022-5347(18)30462-2 ◽

2007 ◽

Vol 177 (4S) ◽

pp. 66-66

Author(s):

Takashi Kobayashi ◽

Rei Goto ◽

Kazuto Ito ◽

Osamu Ogawa

Keyword(s):

Prostate Cancer ◽

Cancer Screening ◽

Prostate Cancer Screening ◽

Specific Antigen ◽

Cost Effective ◽

Screening Strategies

956: Evaluation of Human Glandular Kallikrein 2 and Free Prostate-Specific Antigen Levels as Predictors of Biochemical Recurrence after Radical Prostatectomy for Localized Prostate Cancer

10.1016/s0022-5347(18)35112-7 ◽

2005 ◽

Vol 173 (4S) ◽

pp. 259-259

Author(s):

Thomas Steuber ◽

Alexander Haese ◽

Andrew J. Vickers ◽

Charlotte Becker ◽

Felix K.-H. Chun ◽

...

Keyword(s):

Prostate Cancer ◽

Radical Prostatectomy ◽

Biochemical Recurrence ◽

Specific Antigen ◽

Localized Prostate Cancer ◽

Glandular Kallikrein ◽

Kallikrein 2

1267: Prostate-Specific Antigen Velocity among African-American and White Men Without Prostate Cancer

10.1016/s0022-5347(18)38492-1 ◽

2004 ◽

Vol 171 (4S) ◽

pp. 334-334

Author(s):

Walter J. Simoneaux ◽

Caleb B. Bozeman ◽

Brett S. Carver ◽

Donald A. Elmajian

Keyword(s):

Prostate Cancer ◽

African American ◽

Specific Antigen ◽

White Men

1662: Volume-Based Evaluation of the Ratio of Precursor Prostate-Specific Antigen Isoforms in the Detection of Prostate Cancer

10.1016/s0022-5347(18)38870-0 ◽

2004 ◽

Vol 171 (4S) ◽

pp. 439-440

Author(s):

Yoshio Naya ◽

Herbert A. Fritsche ◽

Viju A. Bhadkamkar ◽

Stephen D. Mikolajczyk ◽

Harry G. Rittenhouse ◽

...

Keyword(s):

Prostate Cancer ◽

Specific Antigen

1804: Should Complexed Prostate-Specific Antigen be the First Line Test for Prostate Cancer Early Detection: Impact on Sensitivity, Rate of Unnecessary Biopsies and Direct Biopsy Costs

10.1016/s0022-5347(18)38996-1 ◽

2004 ◽

Vol 171 (4S) ◽

pp. 477-477

Author(s):

Herbert A. Fritsche ◽

Yoshio Naya ◽

Carol D. Cheli ◽

Richard J. Babaian

Keyword(s):

Prostate Cancer ◽

Early Detection ◽

Specific Antigen ◽

First Line ◽

Cancer Early Detection ◽

Sensitivity Rate ◽

Line Test

1794: Verification Bias in the Assessment of Prostate Specific Antigen (PSA) As a Screening Test for Prostate Cancer

10.1016/s0022-5347(18)38986-9 ◽

2004 ◽

Vol 171 (4S) ◽

pp. 474-474

Author(s):

Amit Gupta ◽

Claus G. Roehrborn

Keyword(s):

Prostate Cancer ◽

Screening Test ◽

Specific Antigen ◽

Verification Bias

1062: Bicalutamide 150 mg in Addition to Standard Care Significantly Improves Prostate Specific Antigen Progression-Free Survival in Patients with Early, Non-Metastatic Prostate Cancer: Median 5.4 Years' follow-up

10.1016/s0022-5347(18)38299-5 ◽

2004 ◽

Vol 171 (4S) ◽

pp. 280-281 ◽

Cited By ~ 2

Author(s):

William A. See ◽

Peter Iversen ◽

David G. McLeod ◽

Manfred P. Wirth ◽

Kevin Carroll ◽

...

Keyword(s):

Prostate Cancer ◽

Standard Care ◽

Metastatic Prostate Cancer ◽

Specific Antigen ◽

Progression Free Survival ◽

Free Survival